Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide followed by zoledronic acid for osteogenesis imperfecta
2016-003228-22Phase 4Unknown
- Sponsor
- University of Edinburgh
- Start
- Oct 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of teriparatide and zoledronic acid in osteogenesis imperfecta (OI) (2 arms), sponsored by University of Edinburgh. Status: unknown.
02
Drugs
teriparatidezoledronic acid
03
Conditions
osteogenesis imperfecta (OI)
Beyond the preview
Go deeper on 2016-003228-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003228-22.